Author

Y. Feng Earley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. J. B. Gayban· 1 shared E. Regalado· 1 shared F. Trebak· 1 shared J. Shi· 1 shared L. A. C. Souza· 1 shared L. Souza· 1 shared P. G. Kehoe· 1 shared Q. Chen· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. J. B. Gayban

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

(Pro)Renin Receptor Antagonism Attenuates High-Fat-Die-Induced Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease

A. J. B. Gayban, L. Souza, S. G. Cooper, E. Regalado, R. Kleemann, Y. Feng Earley

This study shows that PRR antagonism reduces hepatic steatosis and fibrosis in NAFLD models without affecting body weight or glucose levels.

bioRxiv · Sep 7, 2022 · PreprintPathology

Small RNA modifications in Alzheimers disease

X. Zhang, F. Trebak, L. A. C. Souza, J. Shi, T. Zhou, P. G. Kehoe, Q. Chen, Y. Feng Earley

This study identifies altered small RNA modifications in Alzheimer's disease post-mortem samples compared to controls, with specific reductions in certain small RNA types.

Neurobiology of Disease · Nov 1, 2020Peer-reviewedCell Biology